Registrar Corp. introduces Adverse Event Management Software that ‘securely’ intakes sensitive consumer medical data, tracks adverse events for all products globally, transmits information to internal stakeholders and formats serious events to the FDA Medwatch format for submission.

San Diego-based Debut Biotechnology, Inc., which recently expanded an ingredient development partnership with L’Oréal SA, has launched BiotechXBeautyLabs development and contract manufacturing to make it possible for all brands – even those without expertise, proprietary ingredients or investment capability – to join the biotech revolution.

The Personal Care Products Council is actively working with the FDA’s cosmetics office director Linda Katz and principal deputy commissioner Namandje Bumpus to ensure the agency has the tools it needs to continue rolling out MoCRA, says Tom Myers, the association's president and CEO. Also, the 2024 US presidential election and the problem of misinformation.

In addition to sustainability, Myers noted DEI and advancing alternatives to animal testing among key priorities for the group. “We have member companies that really lead the way on many of those. We want to be able to amplify their good work and their messaging, because they are good corporate citizens” and “it’s what consumers are demanding anyway,” he said in an interview.

Oral Essentials filed a Fast-Track SWIFT review case with the National Advertising Division against competitor GuruNanda LLC, whose endorsers claimed its pulling oil could reverse cavities. The marketer agreed to ensure that claims in question were discontinued.

Anna Benevente, director of the Product, Labeling and Ingredient Review Department at consultancy Registrar Corp, offers perspective on the US FDA’s overdue rulemaking proposal for fragrance allergen labeling on cosmetic products under MoCRA, as well as adverse event reporting compliance.